A blockbuster AstraZeneca drug may now be used as an earlier treatment for mantle cell lymphoma (MCL), making ... for this rare and aggressive type of blood cancer. The FDA expanded approval ...

Approval follows results from the Phase III ECHO trial, which demonstrated that Calquence plus chemotherapy reduced the risk of disease progression or death by 27% in patients with previously ...